The latest price target for Humana (NYSE:HUM) was reported by UBS on October 4, 2024. The analyst firm set a price target for $250.00 expecting HUM to rise to within 12 months (a possible 4.17% upside). 60 analyst firms have reported ratings in the last year.

The latest analyst rating for Humana (NYSE:HUM) was provided by UBS, and Humana maintained their neutral rating.

The last upgrade for Humana Inc happened on December 12, 2023 when Argus Research raised their price target to $550. Argus Research previously had a hold for Humana Inc.

The last downgrade for Humana Inc happened on October 3, 2024 when Piper Sandler changed their price target from $392 to $274 for Humana Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Humana, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Humana was filed on October 4, 2024 so you should expect the next rating to be made available sometime around October 4, 2025.

While ratings are subjective and will change, the latest Humana (HUM) rating was a maintained with a price target of $380.00 to $250.00. The current price Humana (HUM) is trading at is $240.00, which is out of the analyst’s predicted range.